Generex Biotechnology Corp. (fka GNBTQ)

[Solar_Express]

NEWS Globenewswire: Reminder: Investor Conference Call Today July 25, 2019 Management to Provide Details on Generex Up-list and 1:1 Stock Dividend

July 25, 2019 09:00 ET | Source: Generex Biotechnology Corporation

MIRAMAR, Fla., July 25, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team today, July 25, 2019 at 4:00 PM Eastern time:

Investors & persons of interest calling into event:

Domestic US/Canada – 1 – 888-632-3385

Direct Toll / International - 1 785-424-1673

Conference ID - 83571

During the investors call Mr. Moscato will provide details on the Generex up-list application to Nasdaq and the timing for the associated 1:1 shareholder stock dividend, which will be paid the day after the Nasdaq listing. Additionally, Mr. Moscato will discuss the timing for the planned spin-out of NuGenerex Immuno-Oncology (NGIO) as a separate, publicly-traded company, together with the proposed merger with Kiromic, a cutting-edge, clinical stage oncology research company with multiple immunotherapeutic platforms, including CAR-T, CAR-NK, oral vaccines, and Artificial Intelligence (AI) Platform for Neo-antigen identification and personalized immunotherapy.